Literature DB >> 20060434

Chromatin remodeling and histone modifications in pituitary tumors.

Toru Tateno1, Xuegong Zhu, Sylvia L Asa, Shereen Ezzat.   

Abstract

Pituitary tumorigenesis infrequently involves intragenic mutations of oncogenes or tumor suppressor genes (Asa and Ezzat, 1998, 2002). Increasing evidence suggests that signals implicated in pituitary development may be relevant to neoplastic changes. Equally as important, accumulating evidence suggests that in contrast to other forms of solid neoplasia, pituitary tumors are frequently associated with epigenetic changes. In this review we discuss evolving models of epigenetic control and use members of the fibroblast growth factor receptor (FGF) receptor family as examples of dysregulated signals in pituitary tumorigenesis (Asa and Ezzat, 2009). 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20060434     DOI: 10.1016/j.mce.2009.12.028

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  7 in total

1.  LRRC4 haplotypes are associated with pituitary adenoma in a Chinese population.

Authors:  Lan Xiao; Chaofeng Tu; Shuai Chen; Zhibin Yu; Qianqian Lei; Zeyou Wang; Gang Xu; Minghua Wu; Guiyuan Li
Journal:  Med Oncol       Date:  2014-02-23       Impact factor: 3.064

Review 2.  Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma.

Authors:  Yunli Zhou; Xun Zhang; Anne Klibanski
Journal:  Mol Cell Endocrinol       Date:  2013-09-11       Impact factor: 4.102

Review 3.  The role of genetic and epigenetic changes in pituitary tumorigenesis.

Authors:  Hidenori Fukuoka; Yutaka Takahashi
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-11-29       Impact factor: 1.742

Review 4.  Architects of Pituitary Tumour Growth.

Authors:  Maria Eugenia Sabatino; Ezequiel Grondona; Ana Lucía De Paul
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

5.  Integrated analysis of competitive endogenous ribose nucleic acids (ceRNAs)-related regulatory networks in invasive and non-invasive non-functioning pituitary adenomas (NFPAs).

Authors:  Jiangtao Liu; Kaixuan Wang; Hongming Ji; Gangli Zhang; Shengli Chen; Shiyuan Zhang; Fake Lu; Changchen Hu
Journal:  Front Surg       Date:  2022-09-29

6.  EZH2 is highly expressed in pituitary adenomas and associated with proliferation.

Authors:  David Schult; Annett Hölsken; Sonja Siegel; Michael Buchfelder; Rudolf Fahlbusch; Ilonka Kreitschmann-Andermahr; Rolf Buslei
Journal:  Sci Rep       Date:  2015-11-23       Impact factor: 4.379

7.  Genetic and expression variations of cell cycle pathway genes in brain tumor patients.

Authors:  Anum Zehra Naqvi; Ishrat Mahjabeen; Saima Ameen; Malik Waqar Ahmed; Asad Ullah Khan; Zertashia Akram; Mahmood Akhtar Kayani
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.